Effectiveness of adjuvant chemotherapy for resected NSCLC

被引：4
|
作者：
Stuschke, Martin [1 ]
Poettgen, Christoph [1 ]
机构：
[1] Univ Duisburg Essen, Dept Radiotherapy, D-45122 Essen, Germany
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2010年 / 7卷 / 11期
关键词：
CELL LUNG-CANCER; RADIOTHERAPY; GUIDELINE; THERAPY; SOCIETY; TRIAL; IIIA;
D O I：
10.1038/nrclinonc.2010.165
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Two meta-analyses of the Non Small Cell Lung Cancer Meta-analyses Collaborative Group (NSCLC MACG) on the effects of adjuvant chemotherapy on early stage NSCLC after complete or curative resection have demonstrated that adjuvant cisplatin-based regimens are a valid and recommendable option following curative surgery. We discuss these results in the light of current interdisciplinary guidelines and existing meta-analyses of randomized clinical trials.
引用
收藏
页码：613 / 614
页数：2
相关论文
共 50 条
  • [31] Adjuvant chemotherapy for resected non-small cell lung cancer (NSCLC): the West of Scotland Experience
    Slater, S.
    Nowicki, S.
    Brown, J.
    Steele, N.
    [J]. LUNG CANCER, 2012, 75 : S11 - S11
  • [32] Survival Data of Postoperative Adjuvant Chemotherapy of Cisplatin plus Vinorelbine for Completely Resected NSCLC: A Retrospective Study
    Kenmotsu, Hirotsugu
    Ohde, Yasuhisa
    Ono, Akira
    Nakashima, Kazuhisa
    Omori, Shota
    Wakuda, Kazushige
    Naito, Tateaki
    Murakami, Haruyasu
    Kojima, Hideaki
    Takahashi, Shoji
    Isaka, Mitsuhiro
    Endo, Masahiro
    Takahashi, Toshiaki
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S866 - S866
  • [33] Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC
    Shen, Zi-Qing
    Feng, Kun-Peng
    Fang, Zi-Yao
    Xia, Tian
    Pan, Shu
    Ding, Cheng
    Xu, Chun
    Ju, Sheng
    Chen, Jun
    Li, Chang
    Zhao, Jun
    [J]. JOURNAL OF CARDIOTHORACIC SURGERY, 2024, 19 (01)
  • [34] Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC
    Zi-Qing Shen
    Kun-Peng Feng
    Zi-Yao Fang
    Tian Xia
    Shu Pan
    Cheng Ding
    Chun Xu
    Sheng Ju
    Jun Chen
    Chang Li
    Jun Zhao
    [J]. Journal of Cardiothoracic Surgery, 19
  • [35] Current status of adjuvant chemotherapy in NSCLC
    Scagliotti, G. V.
    Novello, S.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : V62 - V63
  • [36] Adjuvant Chemotherapy in Resected Biliary Tract Cancer
    Primrose, John N.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (07) : 2127 - 2129
  • [37] Update of Adjuvant Chemotherapy for Resected Gastric Cancer
    Oh, Sang Cheul
    [J]. JOURNAL OF GASTRIC CANCER, 2012, 12 (01) : 3 - 6
  • [38] Adjuvant Chemotherapy in Resected Biliary Tract Cancer
    John N. Primrose
    [J]. Annals of Surgical Oncology, 2020, 27 : 2127 - 2129
  • [39] Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1
    Akinori Hisashige
    Mitsuru Sasako
    Toshifusa Nakajima
    [J]. BMC Cancer, 13
  • [40] Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1
    Hisashige, Akinori
    Sasako, Mitsuru
    Nakajima, Toshifusa
    [J]. BMC CANCER, 2013, 13
12345